Clinical Trial: An Open-label, Single-arm, Exploratory Clinical Study of SBRT Sequential HAIC Combined with Camrelizumab and Apatinib as First-line Treatment for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombus (PVTT) (China)

Posted On: 2026-11-12

China, Nov. 12 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'An Open-label, Single-arm, Exploratory Clinical Study of SBRT Sequential HAIC Combined with Camrelizumab and Apatinib as First-line Treatment for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombus (PVTT)'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600136527

Registration Time: 2026/11/11

Type: Interventional study

Primary Sponsor: The Fifth Medical Center of the PLA General Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=346802

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: An Open-label, Single-arm, Exploratory Clinical Study of SBRT Sequential HAIC Combined with Camrelizumab and Apatinib as First-line Treatment for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombus (PVTT) (China)